- Skyline Medical Inc SKLN shares dropped 19.3 percent to $3.50. Skyline Medical shares have jumped 20.08 percent over the past 52 weeks, while the S&P 500 index has gained 6.39 percent in the same period.
- Cancer Genetics Inc CGIX shares declined 15.6 percent to $1.35.
- BOS Better OnLine Sol (USA) BOSC fell 13.2 percent to $2.04. BOS Better Online Solutions posted a Q3 loss of $0.08 per share.
- Fang Holdings Ltd SFUN shares declined 11.1 percent to $3.05. Fang Holdings posted a Q3 loss of $0.01 per share on revenue of $250.1 million.
- Alder Biopharmaceuticals Inc ALDR fell 10.1 percent to $24.10 after the company disclosed that it has initiated its PROMISE 2 trial.
- Ocular Therapeutix Inc OCUL dropped 9.5 percent to $10.41 after gaining 7.18 percent on Friday.
- Advanced Accelerator Application SA(ADR) AAAP dropped 9.1 percent to $30.72. Advanced Accelerator Applications reported a Q3 loss of $7 million on revenue of $30.0 million.
- PhotoMedex Inc PHMD shares fell 9.1 percent to $2.19 after jumping 46.15 percent on Friday.
- Signal Genetics Inc SGNL shares declined 7.8 percent to $8.72. Signal Genetics disclosed that it has regained compliance with the NASDAQ minimum bid price listing requirement.
- H & R Block Inc HRB fell 7.5 percent to $22.19. BTIG Research downgraded H & R Block from Neutral to Sell.
- Tupperware Brands Corporation TUP declined 5 percent to $56.35. B. Riley downgraded Tupperware from Neutral to Sell.
- Curis, Inc. CRIS dropped 4.8 percent to $3.21. Curis reported the full approval of Roche's Erivedge in the European Union.
Market News and Data brought to you by Benzinga APIs
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
